-

Form 8.3 - UDG Healthcare plc - Amendment

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3 - Amendment to Purchases and Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

  Name of person dealing (Note 1) Barclays PLC.
  Company dealt in UDG HEALTHCARE PLC
  Class of relevant security to which the  ORD
  dealings being disclosed relate (Note 2)
  Date of dealing 05 August 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD    
  Long Short
 

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

 

12,374,055

4.91%

636,357

0.25%

   

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

141,935

0.06%

9,499,914

3.77%

   

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

TOTAL:

 

 

 

 

 

12,515,990

4.97%

10,136,271

4.02%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

23

10.7908   GBP

Purchase

9,014

10.7700   GBP

Purchase

11,048

10.7896   GBP

Purchase

15,137

10.7773   GBP

Purchase

19,254

10.7845   GBP

Purchase

21,523

10.7807   GBP

Purchase

23,366

10.7815   GBP

Purchase

32,826

10.7800   GBP

Purchase

174,121

10.7750   GBP

Purchase

184,067

10.7900   GBP

Purchase

250,000

10.7782   GBP

Purchase

319,338

10.7891   GBP

Sale

922

10.7905   GBP

Sale

983

10.7695   GBP

Sale

1,688

10.7700   GBP

Sale

2,240

10.7817   GBP

Sale

52,884

10.7883   GBP

Sale

97,038

10.7750   GBP

Sale

111,843

10.7900   GBP

(b) Derivatives transactions (other than options transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per

 

 

 

unit

CFD

Long

983

10.7695   GBP

SWAP

Long

1,934

10.7712   GBP

CFD

Long

2,240

10.7817   GBP

CFD

Long

5,100

10.7718   GBP

SWAP

Long

5,711

10.7894   GBP

SWAP

Long

56,643

10.7900   GBP

CFD

Short

23

10.7908   GBP

CFD

Short

24,056

10.7791   GBP

SWAP

Short

33,702

10.7847   GBP

SWAP

Short

130,059

10.7900   GBP

SWAP

Short

260,837

10.7887   GBP

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

9 Aug 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected  
If a connected EFM, state nature of connection  

 

Contacts

BARCLAYS PLC

BARCLAYS PLC

LSE:UDG

Release Versions

Contacts

BARCLAYS PLC

More News From BARCLAYS PLC

BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - STAGECOACH GROUP PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...

BARCLAYS PLC UK Regulatory Announcement: FORM 8.3 - ULTRA ELECTRONICS HOLDINGS PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...

BARCLAYS PLC UK Regulatory Announcement: FORM 8.3 - VIVO ENERGY PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...
Back to Newsroom